scPharmaceuticals SG&A Expense (Quarterly) Analysis

scPharmaceuticals Inc (SCPH)

4.66 0.00 (0.00%) USD | NASDAQ | May 03, 16:00

4.65 -0.01 (-0.21%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2016. Upgrade now.

Date	Value
December 31, 2023	16.24M
September 30, 2023	14.14M
June 30, 2023	12.10M
March 31, 2023	10.90M
December 31, 2022	7.176M
September 30, 2022	6.277M
June 30, 2022	4.279M
March 31, 2022	2.893M
December 31, 2021	2.191M
September 30, 2021	2.211M
June 30, 2021	2.649M
March 31, 2021	2.732M
December 31, 2020	3.425M
September 30, 2020	3.319M
June 30, 2020	2.537M

Date	Value
March 31, 2020	2.503M
December 31, 2019	2.115M
September 30, 2019	1.996M
June 30, 2019	1.839M
March 31, 2019	2.323M
December 31, 2018	2.074M
September 30, 2018	1.945M
June 30, 2018	5.049M
March 31, 2018	4.651M
December 31, 2017	2.992M
September 30, 2017	1.665M
June 30, 2017	2.374M
March 31, 2017	2.074M
December 31, 2016	0.943M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

1.839M

Minimum

Jun 2019

16.24M

Maximum

Dec 2023

5.343M

Average

2.893M

Median

Mar 2022

SG&A Expense (Quarterly) Benchmarks